Click Sign-Up Today to register an account to access your prescriptions. Please note: Your previous login credentials will not work with this new service. Download our NEW Mobile App! See details below!
Tinsley Bible Drug Co. Logo

Get Healthy!

More DNA Errors Seen in Brain Cells of Alzheimer's Patients
  • By Robert Preidt HealthDay Reporter
  • Posted April 22, 2022

More DNA Errors Seen in Brain Cells of Alzheimer's Patients

Genetic mutations build up faster in the brain cells of Alzheimer's disease patients than in other people, new research reveals.

The discovery could point the way to new Alzheimer's treatments.

DNA errors called somatic mutations can occur in brain cells as people age. The authors of this study compared somatic mutations in hippocampal and prefrontal cortex neurons of people with advanced Alzheimer's and people with no neurological conditions.

The Alzheimer's disease (AD) patients had a larger number of mutations - likely due to increased DNA oxidation, according to findings published April 20 in the journal Nature.

"As we age, neurons are known to accumulate somatic mutations. In AD neurons, however, we see more mutations and DNA alterations," said lead study author Dr. Michael Miller, a neuropathologist at Harvard-affiliated Brigham and Women's Hospital in Boston.

"Our results suggest that AD neurons experience genomic damage that causes immense stress on cells and creates dysfunction among them," he added. "These findings may explain why many brain cells die during Alzheimer's disease."

The study provides more insight into the molecular and cellular events involved in the development of Alzheimer's.

"Our findings suggest that the sheer number of oxidative lesions and somatic mutations we observed in AD neurons may contribute to its pathology," Miller said in a hospital news release.

In the future, the researchers are eager to learn more about how the mutations work and to discover novel treatments that target them.

This study included only patients with advanced Alzheimer's, so researchers want to examine the brain cells of people with intermediate-stage Alzheimer's in the future.

More information

For more on Alzheimer's disease, go to the U.S. National Institute on Aging.

SOURCE: Brigham and Women's Hospital, news release, April 20, 2022

HealthDay
Health News is provided as a service to Tinsley Bible Drug Co. site users by HealthDay. Tinsley Bible Drug Co. nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2024 HealthDay All Rights Reserved.